Healthcare
Peppermint Venture Partners et al. back CAP-CMV
Peppermint Venture Partners has led a €800,000 seed financing round for CAP-CMV, a German medical start-up, alongside other investors.
GSK launches $50m venture capital fund
GlaxoSmithKline (GSK) has launched a $50m strategic venture capital fund, Action Potential Venture Capital (APVC), to make investments in the biotech and bioelectric medicines industries.
BayBG invests in puracon
Bayerische Beteiligungsgesellschaft (BayBG) has bought a minority stake in puracon, a supplier of packaging for medical products.
Graphite Capital exits Willowbrook
Graphite Capital has sold its majority stake in Willowbrook Healthcare, an owner of care homes for the elderly, to the company's management.
VC-backed Profibrix sold to big pharma
Index Ventures, Gilde Healthcare Partners, Vesalius Biocapital and Inkef Capital have sold Dutch biotech firm Profibrix to The Medicines Company for a total consideration of $240m.
HTGF backs exelonix in seed round
High-Tech Gründerfonds (HTGF) has provided seed funding to exelonix, a provider of internet-based assistance systems for elderly people.
HTGF's CorTec receives €3m series-A funding
KfW Banking Group and seed investor M-Invest have injected €3m into High-Tech Gründerfonds (HTGF) portfolio company CorTec.
BaltCap offloads Medicap to synlab
Baltic-focused private equity firm BaltCap has sold Medicap Holding to European laboratory services provider synlab.
HTGF backs NovaPump in series-A funding
High-Tech Gründerfonds has invested in medical company NovaPump as part of a series-A funding round.
Waterland sells SLG to Medica
Waterland Private Equity Investments has wholly divested its Belgian portfolio company Senior Living Group (SLG) to Medica, a France-based dependency care provider.
HTGF's Capical receives series-A funding
KfW and M-Invest have invested in Capical, a medical technology company backed by High-Tech Gründerfonds (HTGF), in a series-A funding round.
Imperial et al. back Polytherics and Antitope merger
Imperial Innovations, Mercia Fund Management, Catapult Venture Managers and Invesco Perpetual have provided ТЃ13.5m for the takeover of Antitope by UK-based biotechnology firm Polytherics.
Xanit bolts on Croasa
Xanit International Hospital, the healthcare provider backed by N+1 Mercapital and Partners Group, has completed the bolt-on of oncology centre Croasa.
Atlas leads €2.5m round for Harbour Antibodies
Atlas Venture has led a €2.5m funding round for Rotterdam-based Harbour Antibodies, an engineer of transgenic mice designed to produce high-affinity human antibodies.
Gimv et al. back Jenavalve
A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.
ReNeuron raises £33.2m
Several venture capital investors, including the Wales Life Sciences Investment Fund, have participated in a ТЃ33.2m funding round for stem cell development firm ReNeuron.
UI Gestion injects €15m into GBNA
French GP UI Gestion has provided private healthcare group GBNA with €15m of growth capital funding.
Idinvest et al. back Pathoquest with €3.8m
Idinvest Partners and Aurinvest, as well as existing backer Kurma Life Sciences Partners (KLS), have injected €3.8m into Paris-based biotechnology firm Pathoquest.
Sentica exits 9lives
Sentica Partners has sold Helsinki-based ambulance and emergency care services company 9lives back to the companyтs management.
EdRip in CHF 18m OncoEthix series-B round
Edmond de Rothschild Investment Partners (EdRip) has participated in a series-B funding round totalling CHF 18m for Swiss oncology drug development firm OncoEthix.
Clave Mayor divests Gadea
Spanish venture capital investor Clave Mayor has divested its 9.73% stake in pharmaceuticals company Gadea Grupo Farmacéutico.
Sovereign supports Eden's HASS acquisition
Eden Supported Living, backed by buy-and-build specialist Sovereign Capital, has acquired Housing & Support Solutions (HASS).
Synova-backed Clearwater in bolt-on
Specialist care provider Clearwater Care, a portfolio company of Synova Capital, has acquired TL Care, a UK-based supported-living provider.
Rabo Capital looks to sell DORC
The private equity division of Rabobank, Rabo Capital, is planning to sell portfolio company Dutch Ophthalmic Research Centre (DORC).